Pinned Tweet
Wall Street gives the S&P 500 about 17 analysts a stock. A quarter of public companies get zero.
We're building coverage for all 6,000, starting straight from the filings. 2-minute survey: tell us what you'd actually read 👇
forms.gle/bL5kB2nhSz8LdbGf8
Ingram Micro's gross margin slipped to 6.55% from 6.90%, which the company blamed on lower-margin GPU and AI-infrastructure products.
Excluding those large deals, $INGM's margin was 7.06% against 7.10% a year earlier.
Full Story 👇
$COLM sees mid-single-digit wholesale growth in H1 2027, U.S. and global
Spring order book improved from low-to-mid single digits at the last call
Full-year 2027 guidance comes on the Q4 call
Full Story 👇
$BFAM says the UK regulator's safeguarding notice hit fall enrollment less over the summer than it expects now.
CEO Stephen Kramer said the larger impact lands in Q4 and lasts until the notice is lifted. Q4 revenue guide: $730M to $740M.
Full Story 👇
$COLM's U.S. net sales fell 1% in Q3, which Tim Boyle attributed to delayed wholesale shipments.
But U.S. e-commerce grew mid single digits, high single digits for the Columbia brand, with fewer promotions.
Full Story 👇
A Bain Capital life sciences fund may be deemed to own 9.99% of $ADCT, or 14,825,625 shares.
But it holds 7,000,000 common shares. The rest counts pre-funded warrants, and a blocker bars exercise that would lift it above 9.99%.
Full Story 👇
Healthcare Realty's Q3 Normalized FFO edged up to $0.42 from $0.41, and revenue fell to $286.6M from $297.8M.
Still, $HR raised its 2026 Normalized FFO outlook to $1.65-$1.67 a share, up $0.02 at the midpoint from July.
Full Story 👇
Dexcom's inventory ended September at $770.7M, up from $629.1M at year-end. Finished goods were $462.9M against $266.5M.
$DXCM also booked $33.0M of inventory reserve charges in Q3, tied in part to the planned end of G6 manufacturing.
Full Story 👇
Alnylam now expects 2026 TTR sales at the low end of $4.2B-$4.5B
Cited: cautious Q4 hospital ordering ahead of the 340B rule
Also cited: UnitedHealth's stricter first-line Amvutra policy since Oct. 1
$ALNY
Full Story 👇
$JKHY booked $17.9M of deconversion revenue in its fiscal Q1, and put its fiscal 2027 estimate at $30.0M.
The $17.9M is part of that $30.0M, not on top of it. The estimate is based on the first-quarter result, the company said.
Full Story 👇
$PFSI's production segment went from $38M of pretax income in Q2 to a $7M pretax loss in Q3. Acquisitions and originations fell 30% from the prior quarter to $24.4B.
Servicing earned $99M pretax, up from $22M in Q2.
Full Story 👇
